Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boehringer Ingelheim Animal Health
Duluth, Georgia, United States
- Ownership
- Private
- Employees
- ~10000
- Development stage
- Other
01
Overview
Boehringer Ingelheim Animal Health’s products—including vaccines, therapeutics, and parasite control—are commercialized globally and widely used in veterinary medicine, demonstrating proven benefit in disease prevention and control for both companion and food animals[1][2][3][5].
- Therapeutic areas
- CardiovascularEndocrinologyRheumatologyGastroenterologyInfectious Diseases
- Modalities
- VaccineSmall moleculeBiologicProtein
- Industry
- Veterinary
02
Partnerships
Past major partnership/asset swap with Sanofi (acquisition of Merial)collaborations with academic centers such as Iowa State University[3][7]
Beyond the preview
Go deeper on Boehringer Ingelheim Animal Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Boehringer Ingelheim Animal Health.